OncoCyte Corporation (OCX)
Largest Insider Buys in Sector
OCX Stock Price History Chart
OCX Stock Performance
About OncoCyte Corporation
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a …
Insider Activity of OncoCyte Corporation
Over the last 12 months, insiders at OncoCyte Corporation have bought $11.15M and sold $0 worth of OncoCyte Corporation stock.
On average, over the past 5 years, insiders at OncoCyte Corporation have bought $13.55M and sold $3.47M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BROADWOOD PARTNERS, L.P. (10 percent owner) — $32.81M. Arno Andrew (director) — $199,998. James Andrea S. (Chief Financial Officer) — $100,000.
The last purchase of 1,315,339 shares for transaction amount of $3.88M was made by BROADWOOD PARTNERS, L.P. (10 percent owner) on 2024‑10‑02.
List of Insider Buy and Sell Transactions, OncoCyte Corporation
| 2024-10-02 | 10 percent owner | 1.32M 9.7663% | $2.95 | $3.88M | +0.33% | |||
| 2024-10-02 | Chief Financial Officer | 33,670 0.2519% | $2.97 | $100,000 | +0.33% | |||
| 2024-04-11 | 10 percent owner | 2.42M 28.8149% | $2.92 | $7.06M | -0.51% | |||
| 2024-04-11 | director | 33,898 0.4083% | $2.95 | $99,999 | -0.51% | |||
| 2024-04-11 | CEO and President | 3,390 0.0408% | $2.95 | $10,001 | -0.51% | |||
| 2023-06-14 | director | 30,000 0.0246% | $0.21 | $6,447 | -30.23% | |||
| 2023-04-05 | 10 percent owner | 663,000 0.6681% | $0.30 | $200,027 | -37.96% | |||
| 2023-04-03 | 10 percent owner | 26.83M 23.0078% | $0.30 | $8.09M | -47.13% | |||
| 2022-12-23 | director | 250,000 0.2087% | $0.35 | $87,875 | -43.42% | |||
| 2022-12-23 | director | 75,000 0.0587% | $0.33 | $24,728 | -43.42% | |||
| 2022-12-22 | director | 25,000 0.0218% | $0.28 | $7,125 | -27.12% | |||
| 2022-08-17 | 20,000 0.0168% | $0.87 | $17,400 | -58.47% | ||||
| 2022-08-17 | 7,500 0.0065% | $0.90 | $6,750 | -58.47% | ||||
| 2022-08-16 | President & CEO | 40,000 0.0353% | $0.96 | $38,400 | -59.93% | |||
| 2022-08-15 | 5,000 0.0042% | $0.97 | $4,850 | -61.86% | ||||
| 2022-08-15 | 115,523 0.0974% | $0.97 | $112,057 | -61.86% | ||||
| 2022-08-15 | 10,500 0.0087% | $0.95 | $9,975 | -61.86% | ||||
| 2022-08-15 | 10,000 0.0087% | $1.00 | $10,000 | -61.86% | ||||
| 2022-08-15 | 25,000 0.0202% | $0.93 | $23,250 | -61.86% | ||||
| 2022-06-24 | Sale | 12,517 0.0114% | $1.05 | $13,160 | -58.04% |
Insider Historical Profitability
| BROADWOOD PARTNERS, L.P. | 10 percent owner | 6244405 37.0914% | $2.83 | 13 | 0 | +2.24% |
| Arno Andrew | director | 69054 0.4102% | $2.83 | 6 | 0 | <0.0001% |
| James Andrea S. | Chief Financial Officer | 33670 0.2% | $2.83 | 1 | 0 | |
| Riggs Josh | CEO and President | 3505 0.0208% | $2.83 | 1 | 0 | |
| BROADWOOD CAPITAL INC | 23353697 138.7195% | $2.83 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Broadwood Capital Inc | $7.35M | 18.77 | 2.51M | 0% | +$0 | 0.55 | |
| Awm Investment Company Inc | $2.21M | 5.64 | 754,286 | 0% | +$0 | 0.34 | |
| Pura Vida Investments LLC | $1.54M | 3.92 | 523,928 | -10.73% | -$184,595.86 | 1.1 | |
| The Vanguard Group | $726,267.00 | 1.86 | 247,873 | 0% | +$0 | <0.0001 | |
| Morgan Stanley | $361,008.00 | 0.92 | 123,211 | +0.19% | +$697.34 | <0.0001 |